|
1
|
Cassidy J, Saltz L, Twelves C, Van Cutsem
E, Hoff P, Kang Y, Saini JP, Gilberg F and Cunningham D: Efficacy
of capecitabine versus 5-fluorouracil in colorectal and gastric
cancers: A meta-analysis of individual data from 6171 patients. Ann
Oncol. 22:2604–2609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zeng H and Zhang S: The
updated incidences and mortalities of major cancers in China, 2011.
Chin J Cancer. 34:502–507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sugarbaker PH: Second-look surgery for
colorectal cancer: Revised selection factors and new treatment
options for greater success. Int J Surg Oncol.
2011:9150782011.PubMed/NCBI
|
|
4
|
Liu QZ, Gao XH, Chang WJ, Gong HF, Fu CG,
Zhang W and Cao GW: Expression of ITGB1 predicts prognosis in
colorectal cancer: A large prospective study based on tissue
microarray. Int J Clin Exp Pathol. 8:12802–12810. 2015.PubMed/NCBI
|
|
5
|
Uhry Z, Belot A, Colonna M, Bossard N,
Rogel A, Iwaz J, Mitton N, Grosclaude P and Remontet L: National
cancer incidence is estimated using the incidence/mortality ratio
in countries with local incidence data: Is this estimation correct?
Cancer Epidemiol. 37:270–277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alsop K, Mead L, Smith LD, Royce SG,
Tesoriero AA, Young JP, Haydon A, Grubb G, Giles GG, Jenkins MA, et
al: Low somatic K-ras mutation frequency in colorectal cancer
diagnosed under the age of 45 years. Eur J Cancer. 42:1357–1361.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brink M, de Goeij AF, Weijenberg MP,
Roemen GM, Lentjes MH, Pachen MM, Smits KM, de Bruïne AP, Goldbohm
RA and van den Brandt PA: K-ras oncogene mutations in sporadic
colorectal cancer in the netherlands cohort study. Carcinogenesis.
24:703–710. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jimi S, Yasui T, Hotokezaka M, Shimada K,
Shinagawa Y, Shiozaki H, Tsutsumi N and Takeda S: Clinical features
and prognostic factors of bone metastases from colorectal cancer.
Surg Today. 43:751–756. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lan YT, Chang SC, Yang SH, Lin CC, Wang
HS, Jiang JK, Chen WS, Lin TC, Chiou SH and Lin JK: Comparison of
clinicopathological characteristics and prognosis between early and
late recurrence after curative surgery for colorectal cancer. Am J
Surg. 207:922–930. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vroon A, Heijnen CJ and Kavelaars A: GRKs
and arrestins: Regulators of migration and inflammation. J Leukoc
Biol. 80:1214–1221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raghuwanshi SK, Smith N, Rivers EJ, Thomas
AJ, Sutton N, Hu Y, Mukhopadhyay S, Chen XL, Leung T and Richardson
RM: G protein-coupled receptor kinase 6 deficiency promotes
angiogenesis, tumor progression and metastasis. J Immunol.
190:5329–5336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dorn GW II: GRK mythology: G-protein
receptor kinases in cardiovascular disease. J Mol Med. 87:455–463.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Metaye T, Gibelin H, Perdrisot R and
Kraimps JL: Pathophysiological roles of G-protein-coupled receptor
kinases. Cell Signal. 17:917–928. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Premont RT, Claing A, Vitale N, Freeman
JL, Pitcher JA, Patton WA, Moss J, Vaughan M and Lefkowitz RJ:
Beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled
receptor kinase-associated ADP ribosylation factor
GTPase-activating protein. Proc Natl Acad Sci USA. 95:pp.
14082–14087. 1998; View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahmed MR, Berthet A, Bychkov E, Porras G,
Li Q, Bioulac BH, Carl YT, Bloch B, Kook S, Aubert I, et al:
Lentiviral overexpression of GRK6 alleviates L-dopa-induced
dyskinesia in experimental Parkinson's disease. Sci Transl Med.
2:28ra282010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tiedemann RE, Zhu YX, Schmidt J, Yin H,
Shi CX, Que Q, Basu G, Azorsa D, Perkins LM, Braggio E, et al:
Kinome-wide RNAi studies in human multiple myeloma identify
vulnerable kinase targets, including a lymphoid-restricted kinase,
GRK6. Blood. 115:1594–1604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yao S, Zhong L, Liu J, Feng J, Bian T,
Zhang Q, Chen J, Lv X, Chen J and Liu Y: Prognostic value of
decreased GRK6 expression in lung adenocarcinoma. J Cancer Res Clin
Oncol. 142:2541–2549. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li YP: GRK6 expression in patients with
hepatocellular carcinoma. Asian Pac J Trop Med. 6:220–223. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuan L, Zhang H, Liu J, Rubin JB, Cho YJ,
Shu HK, Schniederjan M and MacDonald TJ: Growth factor
receptor-Src-mediated suppression of GRK6 dysregulates CXCR4
signaling and promotes medulloblastoma migration. Mol Cancer.
12:182013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Altman DG, McShane LM, Sauerbrei W and
Taube SE: Reporting recommendations for tumor marker prognostic
studies (REMARK): Explanation and elaboration. PLoS Med.
9:e10012162012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sobin LH and Fleming ID: TNM
classification of malignant tumors, fifth edition (1997). Union
internationale contre le cancer and the american joint committee on
cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gupta S, Provenzale D, Regenbogen SE,
Hampel H, Slavin TP Jr, Hall MJ, Llor X, Chung DC, Ahnen DJ, Bray
T, et al: NCCN guidelines insights: Genetic/Familial high-risk
assessment: Colorectal, 2008. J Natl Compr Canc Netw. 15:9–20.
2007.
|
|
23
|
Li Q, Zhi X, Zhou J, Tao R, Zhang J, Chen
P, Røe OD, Sun L and Ma L: Circulating tumor cells as a prognostic
and predictive marker in gastrointestinal stromal tumors: A
prospective study. Oncotarget. 7:36645–36654. 2016.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi R, Wang L, Wang T, Xu J, Wang F and Xu
M: NEDD9 overexpression correlates with the progression and
prognosis in gastric carcinoma. Med Oncol. 31:8522014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tian Y, Xu T, Huang J, Zhang L, Xu S,
Xiong B, Wang Y and Tang H: Tissue metabonomic phenotyping for
diagnosis and prognosis of human colorectal cancer. Sci Rep.
6:207902016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ikeda K, Kojima M, Saito N, Sakuyama N,
Koushi K, Watanabe T, Sugihara K, Akimoto T, Ito M and Ochiai A:
Current status of the histopathological assessment, diagnosis and
reporting of colorectal neuroendocrine tumors: A web survey from
the japanese society for cancer of colon and rectum. Pathol Int.
66:94–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shitara K, Mizota A, Yatabe Y, Kondo C,
Nomura M, Yokota T, Takahari D, Ura T and Muro K: Lapatinib plus
trastuzumab for a patient with heavily pre-treated gastric cancer
that progressed after trastuzumab. Jan J Clin Oncol. 41:663–665.
2011. View Article : Google Scholar
|
|
29
|
Chua TC and Merrett ND: Clinicopathologic
factors associated with HER2-positive gastric cancer and its impact
on survival outcomes-a systematic review. Int J Cancer.
130:2845–2856. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Benovic JL and Gomez J: Molecular cloning
and expression of GRK6. A new member of the G protein-coupled
receptor kinase family. J Biol Chem. 268:19521–19527.
1993.PubMed/NCBI
|
|
31
|
Zhou Y, Li RJ, Li M, Liu X, Zhu HY, Ju Z,
Miao X and Xu GY: Overexpression of GRK6 attenuates neuropathic
pain via suppression of CXCR2 in rat dorsal root ganglion. Mol
Pain. 12:17448069166463812016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Willets JM, Challiss RA and Nahorski SR:
Endogenous G protein-coupled receptor kinase 6 Regulates M3
muscarinic acetylcholine receptor phosphorylation and
desensitization in human SH-SY5Y neuroblastoma cells. J Biol Chem.
277:15523–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Y, Lu B, Yang Q, Fearns C, Yates JR
III and Lee JD: Combined integrin phosphoproteomic analyses and
small interfering RNA-based functional screening identify key
regulators for cancer cell adhesion and migration. Cancer Res.
69:3713–3720. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ribas C, Penela P, Murga C, Salcedo A,
García-Hoz C, Jurado-Pueyo M, Aymerich I and Mayor F Jr: The G
protein-coupled receptor kinase (GRK) interactome: Role of GRKs in
GPCR regulation and signaling. Biochim Biophys Acta. 1768:913–922.
2007. View Article : Google Scholar : PubMed/NCBI
|
